NCT05445388 is a NA clinical trial of Aurisvue in Image, Body, sponsored by Erasmus Medical Center.

Who is sponsoring NCT05445388?

NCT05445388 is sponsored by Erasmus Medical Center.

What drugs are being tested in NCT05445388?

Interventions in NCT05445388: Aurisvue.

What condition does NCT05445388 study?

NCT05445388 studies Image, Body.

Is NCT05445388 still recruiting?

NCT05445388 is currently status unknown. Last updated 6 July 2022.

Last reviewed 2022-07-06 · How we verify

NCT05445388

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Feasibility of Middle Ear OCT Imaging

Status unknown NA Last updated 6 July 2022

What this trial tests

NA trial testing Aurisvue in Image, Body in 100 participants. Status unknown.

Timeline

1 August 2022

Primary endpoint
1 August 2023

1 December 2023

Quick facts

Lead sponsor	Erasmus Medical Center
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	device feasibility
Enrollment	100
Start date	1 August 2022
Primary completion	1 August 2023
Estimated completion	1 December 2023

Drugs / interventions tested

Aurisvue

Conditions studied

Image, Body — all drugs for Image, Body →

Sponsor

Erasmus Medical Center

Who can join

18 and older, any sex, with Image, Body. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Feasibility of structural and functional imaging of the middle ear and its constituents by optical coherence tomography.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Image, Body

Currently open trials in the same condition.

NCT05215132 — Investigational MRI Clinical Software and Hardware · Phase 4 · recruiting

Other Erasmus Medical Center trials

Trials by the same sponsor.

NCT07406269 — Clinical Evaluation of AI Decision Support for Early Rehabilitation After Surgery · NA · not yet recruiting
NCT07402109 — CBCT Guided Markerless SBRT for Renal Cell Cancer · NA · recruiting
NCT07383194 — Prediction Models for LDLT Outcomes · not yet recruiting
NCT07426575 — Evaluating the Usability of New Dialysis Bags · not yet recruiting
NCT07329296 — The Regenerative Capacity of the Donor Liver After Living Donor Liver Transplantation: an Ambidirectional Cohort Study · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05445388 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Erasmus Medical Center
Last refreshed: 6 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05445388.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing